Related Experiment Videos
Three case reports of behavioral disinhibition with clonazepam
General Hospital Psychiatry
|March 1, 1987
Abstract:
Recent reports have supported the innovative use of clonazepam in the treatment of various psychiatric conditions. This report alerts clinicians that, although helpful in some patients, clonazepam can cause behavioral disinhibition and worsening of symptoms in other patients.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Skin differences based on age and chronicity of ultraviolet exposure: results from a gene expression profiling study.
The British journal of dermatology·2012
Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin.
Toxicology in vitro : an international journal published in association with BIBRA·2010
Tg.AC genetically altered mouse: assay working group overview of available data.
Toxicologic pathology·2001
Relevance of interrater agreement to violence risk assessment.
Journal of consulting and clinical psychology·2001
The relationship between command hallucinations and violence.
Psychiatric services (Washington, D.C.)·2000
Digital mental health screening within neurological clinical healthcare settings: a systematic review.
General hospital psychiatry·2026
Parenteral clomipramine in inpatient depression: a retrospective cohort study of treatment patterns and patient characteristics.
General hospital psychiatry·2026
Mental disorders and subsequent kidney function decline: A nationwide cohort study in Japan.
General hospital psychiatry·2026
Data-driven subtypes of internalizing and functional somatic symptoms: A hybrid mixture modeling approach.
General hospital psychiatry·2026
Yangjing Capsule Alleviates Spermatogenic Dysfunction in Mice by Inhibiting the QKI-5/p38 MAPK Pathway Through Upregulation of IncRNA NONMMUT031883.2.
Journal of visualized experiments : JoVE·2026
Short interference RNAs in glomerulonephritis: A mini review.
BioImpacts : BI·2026
Sophocarpine Alleviates Airway Epithelial Cell Inflammation in Asthma via Modulating the Cytokine- Cytokine Receptor and JAK2/STAT3 Signaling Pathways.
Drug design, development and therapy·2026